{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:32:43Z","timestamp":1791689563626,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFA0800801"],"award-info":[{"award-number":["2018YFA0800801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873668"],"award-info":[{"award-number":["81873668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070908"],"award-info":[{"award-number":["82070908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["7202153"],"award-info":[{"award-number":["7202153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00223-021-00932-2","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:05:58Z","timestamp":1641427558000},"page":"451-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Specific Characteristic of Hyperplastic Callus in a Larger Cohort of Osteogenesis Imperfecta Type V"],"prefix":"10.1007","volume":"110","author":[{"given":"Wen-bin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-bo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-2252","authenticated-orcid":false,"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"4","key":"932_CR1","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/eje-20-0299","volume":"183","author":"R Marom","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R (2020) Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 183(4):R95-106. https:\/\/doi.org\/10.1530\/eje-20-0299","journal-title":"Eur J Endocrinol"},{"key":"932_CR2","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052. https:\/\/doi.org\/10.1038\/nrdp.2017.52","journal-title":"Nat Rev Dis Primers"},{"key":"932_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cca.2016.09.019","volume":"462","author":"Y Liu","year":"2016","unstructured":"Liu Y, Wang J, Ma D, Lv F, Xu X, Xia W, Jiang Y, Wang O, Xing X, Zhou P, Wang J, Yu W, Li M (2016) Osteogenesis imperfecta type V: genetic and clinical findings in eleven Chinese patients. Clin Chim Acta 462:201\u2013209. https:\/\/doi.org\/10.1016\/j.cca.2016.09.019","journal-title":"Clin Chim Acta"},{"issue":"2","key":"932_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16(2):101\u2013116. https:\/\/doi.org\/10.1136\/jmg.16.2.101","journal-title":"J Med Genet"},{"issue":"9","key":"932_CR5","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ (2000) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15(9):1650\u20131658. https:\/\/doi.org\/10.1359\/jbmr.2000.15.9.1650","journal-title":"J Bone Miner Res"},{"issue":"6","key":"932_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jbmr.2156","volume":"29","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, Semler O, Garbes L, Zimmermann K, Becker J, Wollnik B, Schoenau E, Netzer C (2014) A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset. J Bone Miner Res 29(6):1387\u20131391. https:\/\/doi.org\/10.1002\/jbmr.2156","journal-title":"J Bone Miner Res"},{"issue":"5","key":"932_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajmg.a.36409","volume":"164","author":"E Guill\u00e9n-Navarro","year":"2014","unstructured":"Guill\u00e9n-Navarro E, Ballesta-Mart\u00ednez MJ, Valencia M, Bueno AM, Martinez-Glez V, L\u00f3pez-Gonz\u00e1lez V, Burnyte B, Utkus A, Lapunzina P, Ruiz-Perez VL (2014) Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta. Am J Med Genet A 164(5):1136\u20131142. https:\/\/doi.org\/10.1002\/ajmg.a.36409","journal-title":"Am J Med Genet A"},{"issue":"6","key":"932_CR8","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/jbmr.2173","volume":"29","author":"CR Farber","year":"2014","unstructured":"Farber CR, Reich A, Barnes AM, Becerra P, Rauch F, Cabral WA, Bae A, Quinlan A, Glorieux FH, Clemens TL, Marini JC (2014) A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res 29(6):1402\u20131411. https:\/\/doi.org\/10.1002\/jbmr.2173","journal-title":"J Bone Miner Res"},{"issue":"8","key":"932_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1359\/jbmr.070418","volume":"22","author":"MS Cheung","year":"2007","unstructured":"Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 22(8):1181\u20131186. https:\/\/doi.org\/10.1359\/jbmr.070418","journal-title":"J Bone Miner Res"},{"issue":"5","key":"932_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00256-007-0441-0","volume":"37","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Azouz EM, Glorieux FH, Rauch F (2008) Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skelet Radiol 37(5):465\u2013467. https:\/\/doi.org\/10.1007\/s00256-007-0441-0","journal-title":"Skelet Radiol"},{"issue":"4","key":"932_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s003300050729","volume":"9","author":"I Dobrocky","year":"1999","unstructured":"Dobrocky I, Seidl G, Grill F (1999) MRI and CT features of hyperplastic callus in osteogenesis imperfecta tarda. Eur Radiol 9(4):665\u2013668. https:\/\/doi.org\/10.1007\/s003300050729","journal-title":"Eur Radiol"},{"issue":"1","key":"932_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2106\/00004623-197153010-00010","volume":"53","author":"JV Banta","year":"1971","unstructured":"Banta JV, Schreiber RR, Kulik WJ (1971) Hyperplastic callus formation in osteogenesis imperfecta simulating osteosarcoma. J Bone Joint Surg Am 53(1):115\u2013122","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"932_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s1092-9134(03)00051-0","volume":"7","author":"J Lamovec","year":"2003","unstructured":"Lamovec J, Mozina E, Baebler B (2003) Hyperplastic callus formation in osteogenesis imperfecta. Ann Diagn Pathol 7(4):231\u2013235. https:\/\/doi.org\/10.1016\/s1092-9134(03)00051-0","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"932_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00428-004-0985-5","volume":"444","author":"S Takahashi","year":"2004","unstructured":"Takahashi S, Okada K, Nagasawa H, Shimada Y, Sakamoto H, Itoi E (2004) Osteosarcoma occurring in osteogenesis imperfecta. Virchows Arch 444(5):454\u2013458. https:\/\/doi.org\/10.1007\/s00428-004-0985-5","journal-title":"Virchows Arch"},{"issue":"4","key":"932_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bone.2010.12.013","volume":"48","author":"AV Khadilkar","year":"2011","unstructured":"Khadilkar AV, Sanwalka NJ, Chiplonkar SA, Khadilkar VV, Mughal MZ (2011) Normative data and percentile curves for dual energy X-ray absorptiometry in healthy Indian girls and boys aged 5\u201317 years. Bone 48(4):810\u2013819. https:\/\/doi.org\/10.1016\/j.bone.2010.12.013","journal-title":"Bone"},{"issue":"12","key":"932_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082098","volume":"8","author":"H Xu","year":"2013","unstructured":"Xu H, Zhao Z, Wang H, Ding M, Zhou A, Wang X, Zhang P, Duggan C, Hu FB (2013) Bone mineral density of the spine in 11,898 Chinese infants and young children: a cross-sectional study. PLoS ONE 8(12):e82098. https:\/\/doi.org\/10.1371\/journal.pone.0082098","journal-title":"PLoS ONE"},{"issue":"8","key":"932_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/ajmg.a.36024","volume":"161","author":"OH Kim","year":"2013","unstructured":"Kim OH, Jin DK, Kosaki K, Kim JW, Cho SY, Yoo WJ, Choi IH, Nishimura G, Ikegawa S, Cho TJ (2013) Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients. Am J Med Genet A 161(8):1972\u20131979. https:\/\/doi.org\/10.1002\/ajmg.a.36024","journal-title":"Am J Med Genet A"},{"issue":"7","key":"932_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"JR Shapiro","year":"2013","unstructured":"Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC, Baldridge DM, Bainbridge MN, Cohn DH, Blazo M, Roberts TT, Brennen FS, Wu Y, Gibbs RA, Melvin P, Campeau PM, Lee BH (2013) Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res 28(7):1523\u20131530. https:\/\/doi.org\/10.1002\/jbmr.1891","journal-title":"J Bone Miner Res"},{"issue":"2","key":"932_CR19","doi-asserted-by":"publisher","first-page":"E325","DOI":"10.1210\/jc.2014-3082","volume":"100","author":"A Reich","year":"2015","unstructured":"Reich A, Bae AS, Barnes AM, Cabral WA, Hinek A, Stimec J, Hill SC, Chitayat D, Marini JC (2015) Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. J Clin Endocrinol Metab 100(2):E325-332. https:\/\/doi.org\/10.1210\/jc.2014-3082","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"932_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00774-015-0667-1","volume":"34","author":"N Hanagata","year":"2016","unstructured":"Hanagata N (2016) IFITM5 mutations and osteogenesis imperfecta. J Bone Miner Metab 34(2):123\u2013131. https:\/\/doi.org\/10.1007\/s00774-015-0667-1","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"932_CR21","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/jbmr.2243","volume":"29","author":"A Patoine","year":"2014","unstructured":"Patoine A, Gaumond MH, Jaiswal PK, Fassier F, Rauch F, Moffatt P (2014) Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination. J Bone Miner Res 29(9):2004\u20132016. https:\/\/doi.org\/10.1002\/jbmr.2243","journal-title":"J Bone Miner Res"},{"issue":"3","key":"932_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/mcd.0000000000000279","volume":"28","author":"JY Lim","year":"2019","unstructured":"Lim JY, Bhatia NS, Vasanwala RF, Chay PL, Lim KBL, Khoo PC, Schwarze U, Jamuar SS (2019) A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature. Clin Dysmorphol 28(3):120\u2013125. https:\/\/doi.org\/10.1097\/mcd.0000000000000279","journal-title":"Clin Dysmorphol"},{"issue":"3","key":"932_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00774-010-0221-0","volume":"29","author":"N Hanagata","year":"2011","unstructured":"Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29(3):279\u2013290. https:\/\/doi.org\/10.1007\/s00774-010-0221-0","journal-title":"J Bone Miner Metab"},{"key":"932_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bone.2017.11.013","volume":"107","author":"F Rauch","year":"2018","unstructured":"Rauch F, Geng Y, Lamplugh L, Hekmatnejad B, Gaumond MH, Penney J, Yamanaka Y, Moffatt P (2018) Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice. Bone 107:131\u2013142. https:\/\/doi.org\/10.1016\/j.bone.2017.11.013","journal-title":"Bone"},{"key":"932_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fendo.2019.00375","volume":"10","author":"YJ Cao","year":"2019","unstructured":"Cao YJ, Wei Z, Zhang H, Zhang ZL (2019) Expanding the clinical spectrum of osteogenesis imperfecta type V: 13 additional patients and review. Front Endocrinol (Lausanne) 10:375. https:\/\/doi.org\/10.3389\/fendo.2019.00375","journal-title":"Front Endocrinol (Lausanne)"},{"key":"932_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijscr.2020.03.024","volume":"69","author":"HC Vonderlind","year":"2020","unstructured":"Vonderlind HC, Jessel M, Knobel A, Juergensen I, Struewer J (2020) Late onset hyperplastic callus formation in osteogenesis imperfecta type V simulating osteosarcoma-A case report. Int J Surg Case Rep 69:83\u201386. https:\/\/doi.org\/10.1016\/j.ijscr.2020.03.024","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"932_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00256-005-0039-3","volume":"35","author":"RL Vieira","year":"2006","unstructured":"Vieira RL, Amaral DT, Jesus-Garcia FR, Saraiva G, Fernandes AR, Resnick D (2006) Hyperplastic callus formation in osteogenesis imperfecta type V mimicking osteosarcoma: 4-year follow-up with resolution. Skelet Radiol 35(6):402\u2013405. https:\/\/doi.org\/10.1007\/s00256-005-0039-3","journal-title":"Skelet Radiol"},{"issue":"9252","key":"932_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s0140-6736(00)03607-2","volume":"357","author":"R Smith","year":"2001","unstructured":"Smith R (2001) Hyperplastic callus and osteogenesis imperfecta. Lancet 357(9252):248\u2013249. https:\/\/doi.org\/10.1016\/s0140-6736(00)03607-2","journal-title":"Lancet"},{"key":"932_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115835","volume":"145","author":"MP Whyte","year":"2021","unstructured":"Whyte MP, Aronson J, McAlister WH, Weinstein RS, Wenkert D, Clements KL, Gottesman GS, Madson KL, Stolina M, Bijanki VN, Plotkin H, Huskey M, Duan S, Mumm S (2021) Coalescing expansile skeletal disease: delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V. Bone 145:115835. https:\/\/doi.org\/10.1016\/j.bone.2020.115835","journal-title":"Bone"},{"key":"932_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115835","volume":"145","author":"MP Whyte","year":"2020","unstructured":"Whyte MP, Aronson J, McAlister WH, Weinstein RS, Wenkert D, Clements KL, Gottesman GS, Madson KL, Stolina M, Bijanki VN, Plotkin H, Huskey M, Duan S, Mumm S (2020) Coalescing expansile skeletal disease: delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V. Bone 145:115835. https:\/\/doi.org\/10.1016\/j.bone.2020.115835","journal-title":"Bone"},{"issue":"4","key":"932_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000439506","volume":"6","author":"E Brizola","year":"2015","unstructured":"Brizola E, Mattos EP, Ferrari J, Freire PO, Germer R, Llerena JC Jr, F\u00e9lix TM (2015) Clinical and molecular characterization of osteogenesis imperfecta type V. Mol Syndromol 6(4):164\u2013172. https:\/\/doi.org\/10.1159\/000439506","journal-title":"Mol Syndromol"},{"issue":"1","key":"932_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/ol.2016.5426","volume":"13","author":"BY Liu","year":"2017","unstructured":"Liu BY, Lu YQ, Han F, Wang Y, Mo XK, Han JX (2017) Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells. Oncol Lett 13(1):111\u2013118. https:\/\/doi.org\/10.3892\/ol.2016.5426","journal-title":"Oncol Lett"},{"issue":"3","key":"932_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s13312-016-0830-3","volume":"53","author":"P Ranganath","year":"2016","unstructured":"Ranganath P, Stephen J, Iyengar R, Phadke SR (2016) Worsening of callus hyperplasia after bisphosphonate treatment in type V osteogenesis imperfecta. Indian Pediatr 53(3):250\u2013252. https:\/\/doi.org\/10.1007\/s13312-016-0830-3","journal-title":"Indian Pediatr"},{"key":"932_CR34","first-page":"83","volume":"1","author":"WH Battle","year":"1908","unstructured":"Battle WH, Shattock SG (1908) A remarkable case of diffuse cancellous osteoma of the femur, following a fracture, in which similar growths afterwards developed in connection with other bones. Proc R Soc Med 1:83\u2013115","journal-title":"Proc R Soc Med"},{"issue":"2","key":"932_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/01.bpb.0000043724.21564.32","volume":"12","author":"N Ram\u00edrez","year":"2003","unstructured":"Ram\u00edrez N, Vilella FE, Col\u00f3n M, Flynn JM (2003) Osteogenesis imperfecta and hyperplastic callus formation in a family: a report of three cases and a review of the literature. J Pediatr Orthop B 12(2):88\u201396. https:\/\/doi.org\/10.1097\/01.bpb.0000043724.21564.32","journal-title":"J Pediatr Orthop B"},{"issue":"12","key":"932_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s002560050324","volume":"26","author":"EM Azouz","year":"1997","unstructured":"Azouz EM, Fassier F (1997) Hyperplastic callus formation in OI. Skelet Radiol 26(12):744\u2013745. https:\/\/doi.org\/10.1007\/s002560050324","journal-title":"Skelet Radiol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00932-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00932-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T14:06:46Z","timestamp":1647439606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00932-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["932"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00932-2","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wen-bin Zheng, Jing Hu, Jia Zhang, Zheng Yang, Ou Wang, Yan Jiang, Wei-bo Xia, Xiao-ping Xing, Wei Yu, and Mei Li declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Informed consent was obtained from the patients or their guardians in the study. They agreed to participate in this study and agree for publication of relevant research results. The study protocol was approved by the Scientific Research Ethics Committee of PUMCH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}